A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Enrolling by invitation · Phase 1

Conditions studied: Healthy Adult Volunteer

In brief

Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Key facts

Study ID

NCT07364877

Run by

Daewon Pharmaceutical Co., Ltd.

People needed

38

Starts

2025-12-28

Expected to finish

2026-05-18

Last updated by the study team

2026-01-23

Who can join

Age: 19 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adult aged 19 to 50 (inclusive) years
• Subjects weighing between 50 kg and 90 kg with BMI between 18 and 27 kg/m2 (inclusive)

You may not qualify if…

• clinical significant liver, kidney, nervous system, respiratory, endocrine, hematology and oncology, cardiovascular, urinary, and mental diseases or past history

Where it is running

• Chungbuk National University Hospital — Cheongju-si, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.